On the other hand, liraglutide or saline were infused into apoE / mice for total of 4 weeks
Sex, body size, reproductive health, gastrointestinal tolerance, and other medicines may affect risk
Short-acting GLP-1 RAs (e.g., exenatide, lixisenatide) were found to have a reduced impact on overnight and fasting blood glucose levels, while long-acting GLP-1 RAs (liraglutide, exenatide once weekly, dulaglutide, and semaglutide) were found to have an increased effect and better coverage on overnight and fasting blood glucose and HbA1c levels [18]
One double-blind randomized controlled study with a 5-strain formulation containing live Akkermansia muciniphila found that after completing 12 weeks of supplementation, 20% of participants had signs of gut colonization even after a 6-month washout period (meaning no probiotics were ingested)
This guide covers every major GLP-1 drug pipeline candidate worth watching in 2026: the compounds already approved, the assets awaiting regulatory decisions, and the emerging molecules that could define the next decade of metabolic medicine
STEP 1 semaglutide obesity trial Trial Primary trial source for semaglutide 2.4 mg weight-loss expectations and side effects